LOS ANGELES—O-Rings Products L.L.C. has received Federal Drug Administration clearance for its patented O-Ring Condom.
The company has received 19 related patents for O-Ring Condom covering 34 countries, including the U.S., Brazil, Canada, China, India, Japan, South Korea and throughout the European Union.
Officials at the firm are in the early stages of discussions with manufacturers to produce the product and distributors, the firm said.
The new condom solves a problem found by studies at Indiana University and the Kinsey Institute. O-Rings Products said the studies claim that at least 30 percent of the time, condoms are initially applied upside down, causing a number of potential risks, including physical discomfort, STI transmission and unintended pregnancies.
Sometimes, users who become frustrated are less likely to use condom consistently, the company said.
O-Rings Products new condom is effective because of its simplicity, the company said, because any user can easily understand the adaptation.